Preparation of Enriched B-and T-Cell Populations. B-cell enriched populations were obtained
by treating whole murine spleen cell populations with mouse anti-Thy-l.2 serum plus complement (C). In brief, portions of 1 × 10 s spleen cells were first incubated (30 min, 4°C) with an appropriate amount of anti-Thy-l.2 serum (AKR anti-C3H), kindly provided by Dr. D. Katz (Scripps Clinic and Research Foundation), prepared as described (11) . After 30 min, cell suspensions were washed once in medium without FBS and incubated for 45 min at 37°C in guinea pig serum (source of C) diluted 1:4 in medium without FBS. Cells were washed again twice with medium and subjected to Ficoll-Hypaque centrifugation. Live cells recovered from the interface were washed and brought to 2 × 106 cells/ml medium. More than 97% of these cells bore surface Ig as evidenced by staining with FITC-F(ab')2 rabbit anti-mouse Ig.
T cell-enriched populations were obtained by using the fluorescence-activated cell sorter (FACS II; Becton, Dickinson & Co., Mountain View, Calif.) as follows: Spleen cells were first subjected to Ficoll-Hypaque centrifugation to remove dead cells. Thereafter, cells at the interface were washed and stained with an optimum amount of FITC-F(ab')2 rabbit antimouse Ig antibody, washed three times in medium containing 0.1% NaNa and brought to 2 X 106 cells/ml medium before being subjected to cell sorting. FITC-stained cell suspensions were sorted on the basis of bright fluorescence as previously described (12) . Bright cells were contaminated with up to 1% of dull cells, and dull cells were contaminated with up to 0.2% of bright cells as judged by repeat analysis of sorted cells in the regular fluorescence microscope. The dull cells (>95% stained when incubated with FITC rabbit anti-mouse brain antibody) were considered to represent T cells.
The Reverse Hemolytic Plaque Assay. IgSC were detected by a reverse hemolytic plaque assay that has been described in detail (13) . Briefly, 50 #l of a 10% suspension of sheep erythrocytes (SRBC) previously coated by the chromium chloride method (14) with an optimum amount of a rabbi't anti-mouse IgM, • antibody and 100/11 of a lymphocyte suspension in medium (1-2 x 105 cells depending on the strain used) were pipetted into 10-X 75-mm glass test tubes (Scientific Products Div., American Hospital Supply Corp., McGraw Park, Ill.) containing 0.5 ml of a 0.5% solution of agarose (Indubiose A.37, L'Industrie Biologique Francaise SA, Gennevilliers, France) in medium. The contents were mixed and poured on microscope slides and allowed to gel. After incubation for 1 h at 37°C, the slides were floated in predetermined optimum dilutions of developing rabbit anti-mouse Ig, anti-mouse IgM, or anti-mouse IgG antiserum and incubated for 1 h at 37°C. The developing antiserum was replaced with 20% guinea pig serum (Pel Freeze, Rogers, Ark.) as a source of C and then incubated for 1 final h at 37°C. IgSC were then detected as hemolytic plaques by using a dissecting microscope (Bausch and Lomb, Rochester, N. Y.).
To determine the in vitro roles of T cells in spontaneous Ig secretion, we assessed the frequency of IgSC in 2 × 105 cells of a whole spleen cell population compared to that of 2 × 105 cells in a population from which T cells had been depleted as described above. On the basis of the results obtained and the predetermined proportion of T cells in the whole spleen cell population, the predicted frequencies of IgSC in the depleted population were determined. The percent reduction in IgSC by T-cell removal was determined by the formula:
Net IgSC/106 T cell depleted population Percent reduction = 1 -× 100. Net IgSC predicted/106 T cell depleted population
The same procedure, adapted from Bell et al. (15) and Roder et al. (16) , was used for enumerating anti-single-strand DNA (ss-DNA)-secreting cells, the only difference being that SRBC were coupled with ss-DNA by the chromic chloride method. Calf thymus DNA (Worthington Biochemical Corp., Freehold, N. J.) was rendered single stranded by heating to 100°C for 12 min, followed by rapid cooling in an ice bath. The binding of DNA to erythrocytes was assessed by a microhemagglutination assay using a human SLE serum with anti-DNA activity. The net numbers of anti-DNA plaques were determined by subtracting the plaques obtained with uncoupled SRBC. The net PFC obtained were inhibited in a dose-dependent manner if free ss-DNA was added in the agarose.
Culturing of Cells for the Generation of IgSC.
Apart from determining the frequency of IgSC present in freshly obtained cell populations (spontaneous IgSC), we also determined the frequency of IgSC after culturing in vitro with and without bacterial LPS. Unseparated spleen cells, as well as T and B cells, and combinations thereof (Results), were suspended at a density of 1 × 106 cells/ml in RPMI-1640 medium (Microbiological Associates, Bethesda, Md.) supplemented with 5% FBS (from a lot predetermined to have low mitogenic activity), penicillin, streptomycin and fungizone, and 2 mM L-glutamine. Portions of 200/~1 (1-2 × 10 ~ cells) were cultured 3 d at 37°C in 5% CO2 in the presence or absence of LPS. At the termination of culture, the cells were washed twice in medium and assayed for the number of IgSC.
Suppression of Spontaneous and Mitogen-induced IgSC.
To study the effect and state of suppressor T cells and their products on the spontaneous IgSC, spleen cells were cultured for 48 h either in RPMI-1640 medium alone or in medium to which various amounts (0.5-20 #g/well) of concanavalin A (Con A) had been added. To study the effect of suppressor T cells on the LPSinduced IgSC, we used direct and indirect assays as described (3) . For the direct assay, spleen cells were cultured for 3 d with 20 ~g/well of LPS and with Con A in amounts ranging from 0.5 to I0/~g/well or without Con A and washed twice, after which the frequency of IgSC was determined. In the indirect assay, spleen cells (2 × 105) were incubated with various amounts (2-20/×g/well) of Con A for 48 h along with untreated controls in RPMI-1640 supplemented as above. These Con A-preactivated cells were then washed twice and added to fresh cultures containing 2 × l0 s cells of the indicated splenocytes together with 20 ~tg/well of LPS. IgSC were enumerated at day 3. Controls with LPS-stimulated cells that did not receive Con Apreactivated cells were also included.
Detection of Cells Staining for Intracytoplasmic Ig. Aliquots of erythrocyte-depleted spleen cells
were analyzed for cytoplasmic Ig after fixation in a 5% acetic acid, 95% ethanol solution at -20°C followed by washing and staining with FITC-F(ab')2 anti-moUse Ig and subsequent processing in the FACS II.
Results
Spontaneous IgSC in Spleens of Autoimmune and Normal Mice. For assessing the state of spontaneous Ig secretion, spleen cells were plaqued immediately after they were obtained. The results of this experiment are depicted in Fig. 1 and indicate that at the stage of clinically obvious disease, four of the five autoimmune strains (NZB, NZB × W, MRL/I and BXSB) had four-to sixfold higher frequencies of IgSC (0.4-0.6% of the whole spleen cell population) than the three immunologically normal H-2-matched strains (BALB/c, C3H/St, C57BL/6). The MRL/n autoimmune strain, which develops the disease in the second year of life, although showing some tendency to increase in frequency of IgSC with age, was within the normal limits at the latest time tested (7 mo of age). Similarly, BXSB females, which develop delayed autoimmune disease, were within the normal limits at the latest time tested (6 mo of age). In the NZB and NZB × W mice, the high frequency of splenic IgSC was detectable as early as 1 mo of age and increased somewhat thereafter. In contrast, in BXSB male and MRL/I female mice the high frequency of IgSC was first observed at or a little before the clinical onset of the disease (3 mo of age).
The number of IgSC in freshly prepared peripheral blood was also determined. Although the frequency of IgSC in peripheral blood was lower than that in syngeneic spleens, the trends were similar, i.e., autoimmune mice had severalfold higher frequency of IgSC than normal strains (Table I) .
IgSC Represent Active Ig Secretion. Because the presence of thymocytotoxic and cytophilic antibodies on cell surfaces may lead to false-positive plaques, we performed two types of experiments to demonstrate that the spontaneous plaques reflected active Ig secretion by lymphoid cells rather than release of Ig passively bound to cells. First, spleen cells taken from five NZB mice at 6 mo of age were preincubated for 2 h at 37°C in medium containing 5% FBS to allow for release of cytophilic antibodies. After the ceils were washed three times, the number of IgSC was determined and Fig. 2 . After 24 h of culture, there was a 60% reduction and at 48 h there was a 76.5% reduction in the number of IgSC compared to the starting value in NZB spleen cells. Second, the action of cycloheximide, an inhibitor of protein synthesis, on the number of IgSC was also examined. Some of the pooled spleen cells from three NZB mice were assayed immediately after they were obtained, and others were incubated with medium or with medium containing cycloheximide (100 ~g/ml) for 2 h at 37°C and then assayed for the number of IgSC. Spleen cells incubated for 2 h at 37°C in medium alone had almost the same frequency of IgSC as cells that were not incubated (4, 328 versus 4,180 IgSC/106 cells). However, incubation for 2 h with cycloheximide decreased the number of IgSC to 112/106 spleen cells. Cell viabilities, as determined by trypan blue exclusion, were identical in treated and untreated populations.
The number ofspontaneeus IgSC detected by the hemolytic plaque assay correlated with the number of Ig-synthesizing cells found by staining for intracytoplasmic Ig with FITC-anti-mouse Ig (Table II) . Older NZB, NZB X W, and MRL/I strains had higher frequencies and numbers of intracytoplasmic Ig-containing cells than the normal strains; ~6-7% of the total spleen cells in the former vs. 1.3% in the latter. In older BXSB mice, the frequency of Ig-containing cells was only two to three times higher than that of older normal mice. With advanced clinical disease, NZ mice had 5-to 10-fold and MRL/1 mice had a 30-fold higher number of Ig-containing cells than younger, syngeneic animals.
Isotypes of lg Secreted Spontaneously by Splenic Lymphocytes. By developing the plaques
with antisera specific for the two major murine isotypes, IgG and IgM, we found that all autoimmune and normal strains tested during youth spontaneously formed con- siderably higher frequencies of IgM-secreting cells than IgG-secreting cells (Table III) . However, in contrast to immunologically normal strains, which show almost the same magnitude and isotype profile of Ig secretion in youth and advanced age, the older autoimmune mice not only had higher frequencies of total IgSC as well as IgG-and IgM-secreting cells than the younger mice, but also they switched from predominantly the IgM isotype at youth to predominantly the IgG isotype. The increase in frequencies of IgGSC in older as compared to young autoimmune mice was approximately fivefold for the NZ and BXSB mice and 11-fold for the MRL/1 strain. The sum of the IgG-and IgM-secreting cells in all mice tested approached the total number of spontaneous IgSC.
Frequency of Spontaneous Autoantibody Secreting Cells.
Because one of the major autoimmune responses in all SLE mice is that directed against DNA, we assessed the proportion of anti-ss-DNA-secreting cells of the total spontaneous IgSC cells of young and old mice (Table IV) . Young mice, both autoimmune and normal, had very low frequencies of anti-ss-DNA-secreting cells in their spleens. As expected, spleens of the older autoimmune mice contained a significantly higher number of anti-ssDNAsecreting cells than spleens of the normal mice; these numbers were highest in older NZB × W and MRL/I mice followed by NZB and BXSB mice. In older MRL/1 and NZ mice, -1 of 5-10 of spontaneous IgSC secreted anti-ss-DNA antibodies (0.05-0.09% of the total spleen cell population). In BXSB mice, 1 of 29 IgSC secreted antiss-DNA antibodies (0.009% of the total spleen population).
Effect of T cells on the Frequency of Spontaneous IgSC.
The influence of T cells on the spontaneous synthesis and secretion of Ig by murine spleen cells was then investigated in vitro. As shown in Table V , removal of T cells resulted in a significant reduction of the frequency of IgSC in both autoimmune and normal spleen cell populations.
The reduction was greater in T-depleted spleen cells of older MRL/1 mice than in the young ones. It should be emphasized that the lymphocytes used in these experiments were not triggered with mitogens and were cultured only long enough to complete the assay (3 h).
Effect of Polyclonal B-CeU Stimulators (LPS) on IgSC.
The ability of LPS to induce or maintain splenic B-cell differentiation and Ig secretion, as well as the optimum dose for this mitogen, were examined after preliminary studies indicated that the response in both normal and autoimmune mice was highest on the third day of culture. As depicted in Fig. 3 , spleen cells from 1-mo-old NZB X W and NZB mice stimulated with LPS (0.02 #g/well) had a 5-to 10-fold higher frequency of IgSC cells than spleen cells from the two other autoimmune strains (MRL/I, BXSB) or several normal strains. However, even cells from NZ mice incubated for 3 d with optimal amounts of 7.5- LPS did not have a substantially higher frequency of IgSC than isogeneic spleen cells freshly obtained and plaqued immediately (compare with Fig. 1 ). It should be reiterated that the spontaneous IgSC decreased substantially within 72 h in the absence of LPS. As shown in Fig. 4 , the frequency of IgSC generated by LPS was greatly reduced in all older autoimmune mice as compared to young animals. The reduction in LPS responsiveness was acutely apparent with the onset of the disease. However, no similar reduction occurred in age-matched, immunologically normal strains (C57BL/6, C3H/ St). response of T-depleted cells (with anti-Thy-l.2 + C) was ~10-25% that of whole spleen populations (Fig. 5A ). Adding increments of T cells to depleted populations restored the levels of IgSC almost to that obtained with whole spleen cell populations (Fig. 5 B) . Control cultures of T cells alone gave no (<25) plaques.
Degree of T-Helper Activity in Various Murine Spleen Cell Populations to LPS-induced Ig Secretion.
Because Ig hypersecretion is more prominent in older autoimmune mice than young ones, and because such hypersecretion may, at least in part, result from heightened T-helper activity, we examined the degree of help provided by increasing numbers of isolated T cells from young and older animals to a standard number of LPS-stimulated syngeneic and allogeneic but H-2-identical B cells isolated from spleens of young animals. The results of these experiments are summarized in Fig. 6 . Increments ofT cells from young and older NZB and BXSB autoimmune mice added to a standard number of B cells from syngeneic young mice (1 mo old) provided--at all doses and at both ages--equal help in enhancing the frequency of IgSC after LPS stimulation. Moreover, the help provided by T cells from these two autoimmune strains to their own B ceils was not significantly different from that provided by T cells from young and older normal mice of the same H-2 haplotype (BALB/c for NZB, C57BL/6 for BXSB). Similarly, in the reverse situation, when T ceils from young and old NZB and BXSB mice were added to B cells from young, normal counterparts, the help was not significantly greater than that from T cells of the normal strains (data not shown). The only notable exception was the MRL/I strain in which T cell-enriched populations from older animals provided twice the help offered by T cells of young syngeneic animals or T cells from young and older normal mice of the same H-2 haplotype (C3H/St).
Effect of Polyclonal T-Cell Stimulation (Con A). Spleen cell suspensions from young
and old normal and autoimmune mice were cultured for 2 d with varying concentrations of Con A (Fig. 7) . The frequency of IgSC was significantly suppressed in vitro in all autoimmune and normal murine strains tested when 5-10/tg of Con A was included in the culture; however, these doses of Con A had no apparent effect on cell viability. Much lower concentrations of Con A (0.05-1.0/Lg) either had no effect on the frequency of IgSC, or in some experiments, actually enhanced the response in all strains examined.
Effect of Con A on LPS-induced Ig Secretion. Con A-activated spleen cells have been
found to suppress the polyclonal response induced by several B-cell mitogens, including LPS (17) (18) (19) . However, it has been reported that Con A-treated spleen cells from older NZB and NZB × W mice, in contrast to the cells from normal mice of similar age, lack the ability to suppress polyclonal B-cell mitogen-induced Ig secretion (5, 8) . Therefore, we examined the direct effect of Con A on LPS-induced stimulation of Ig synthesis by culturing spleen cells with a standard amount of LPS and increasing amounts of Con A. As shown in Fig. 8 , high doses of Con A effectively suppressed LPS-induced Ig synthesis by splenic cells not only from young and older normal mice but also from young and older autoimmune mice, including the NZB and NZB X W strain. It is important to emphasize that in these experiments spleen cells from the older autoimmune mice were chosen only when adequately responsive to LPS. These results were reassessed by incubating spleen cells from young and older mice for 2 d with varying doses of Con A (0-20 #g/well), washing these cells and then adding them to fresh syngeneic cells derived from both young and older animals to which a standard amount of LPS was added. After 3 d, the cocultures were examined for the frequency of IgSC. As seen in Fig. 9A and B, spleen cells from both young and older autoimmune anima!s generated Con A-induced suppressor cell activity, and LPS-responding B cells of young and old syngeneic animals were equally receptive to suppressor messages. That LPS-stimulated B cells of autoimmune mice had no apparent defect in the ability to receive suppressor signals (directly or indirectly delivered to them) was also shown when Con A-preactivated BALB/c spleen cells suppressed spleen cells both from syngeneic young and older animals and from young and older NZB mice (Fig. 9 B, right panel) . 
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Discussion
Our work had two principal aims. The first was to examine, by means of spontaneous and mitogen-induced Ig secretion in vitro, the maturational stage of splenic B lymphocytes obtained during youth and advanced age from SLE-prone and immunologically normal murine strains. The second was to analyze the helper and suppressor effect of their T cells on the secretion of Ig by syngeneic and allogeneic but H-2 identical B cells. Our results indicate that all of the SLE-prone strains have in their spleens at one time or another greater frequencies and numbers of mature B cells than the normal strains. Moreover, the B cell hyperactivity appears not to be the result of a defective T suppressor cell activity or of a lack of acceptor sites for Tsuppressor messages on the B-cell surfaces. Several lines of evidence from other studies as well as these suggest that the B-cell hyperactivity in NZ mice may develop from an intrinsic defect, whereas a contributing factor in MRL/1 mice may be enhanced Thelper cell activity.
The advanced maturity of the B cells from NZ mice, evidenced by the high frequency of IgSC in their spleens, was detectable at 1 mo of age, the earliest age examined. This finding confirms the results of others who observed hypersecretion of Ig (2, 3) and high frequencies of IgSC (20) within the first days of life among these mice. Moreover, the high frequencies of IgSC in our study and those of Manny et al. (24) , whereas the latter finding may be explained on the basis of recruitment and differentiation of virtually all potentially reactive B cells such that few B cells are available to generate antibody when challenged in vitro with a polyclonal B cell activator. Collectively, these findings clearly demonstrate the exceptionally early maturity and hyperactivity of B cells in NZ mice.
The increased frequency of mature B cells, although apparent even at birth in NZ mice, is delayed for several months until just before the clinical onset of the disease in MRL/1 and BXSB mice, yet the two latter strains develop disease earlier than NZ mice. The reason for this disparity between onset of B cell hyperactivity and onset of disease is not clear, but the immunopathologic processes may be more dependent upon the amount and/or quality (class, affinity) of specific autoantibodies produced than the time when nonspecific B-cell hyperactivity appears. In fact, isoelectric focusing studies (25) have shown that immediately before the disease begins, all SLEprone strains exhibit new clonotypes of autoantibodies.
The number of mature B cells increased with the progression of the disease in all autoimmune strains. Of particular interest, at the time when clinical disease began, the IgSC in all these strains switched from a predominantly IgM to a predominantly IgG phenotype. This finding is in agreement with levels of these two isotypes in the sera of these mice (1), with the isotypes of autoantibodies deposited in their kidneys (1) , and with the observation of others that anti-DNA antibodies in sera ofNZB × W mice (26) and anti-DNA-containing supernates of cultured lymphocytes from all autoimmune strains (27) eventually switch from IgM to IgG later in the lives of these animals. Moreover, our finding correlates with our previous observation that the frequency of surface IgG + cells increases with age in spleens of autoimmune mice (10) . Lymphocytes that bear IgG are known to differentiate to IgG-secreting cells and to exert negative influences on IgM secretion (28, 29) .
A relatively large proportion (=15%) of the total IgSC in all older SLE mice spontaneously secreted antibodies against DNA, one of the major autoantigens involved in their disease. A similar frequency of spontaneous anti-ssDNA antibodysecreting cells has been described in NZB mice (15) . Although in our study and others (15, 16) , serum anti-DNA titers in the various strains correlated with the number of anti-DNA secreting cells, the foregoing analysis of auto-antibody production at the cellular level offers the advantage that one can examine factors affecting production and affinity of antibodies without interference by antigen. What proportion of the total IgSC is engaged in producing antibodies against the plethora of autoantigens involved in this disease was not determined, but preliminary studies (data not shown) indicate that ~ 1-2% of the IgSC cells secreted autoantibodies against retroviral gp70, another major autoantigen. Approximately 0.001% of the total NZB spleen cells secrete antibodies against thymocytes in the presence of LPS (30) .
The spontaneous Ig secretion in vitro of both autoimmune and normal spleen cells was dependent to some degree on the presence of T cells, as others (31) found with human peripheral lymphocytes. The precise mechanism by which helper T cells induce precursor B cells to secrete Ig remains poorly understood. However, reduction of Ig secretion after T-cell removal would suggest that in vivo Ig production is more under the influence of helper than suppressor cells. Reconstitution experiments with isolated T and B cells are needed to assure that Ig secretion depends on T cells in vitro.
Nonspecific activation of lymphocytes by mitogens has long been used as a model for the study of antigen-induced activation. We found that the frequency of IgSC produced by normal and autoimmune mice after LPS stimulation was similar to the frequency of spontaneously produced IgSC, a finding similar to that of Manny et al. (3) . However, spleen cells from young NZ mice were much more sensitive to LPS than the cells of other autoimmune and normal strains. It is possible that the enhanced B-cell maturity in NZ mice may result from the presence of low levels of endogenous polyclonal B cell activators.
Polyclonal activation of B cells to secrete Ig is generally thought to depend only upon the direct interaction between LPS and its target B cell. However, we and others (32, 33) have convincing evidence to support the thesis that LPS-induced polyclonal B-cell activation in the mouse is regulated by T cells. Thus, although Ig was secreted in B cell-enriched populations, this phenomenon was markedly enhanced in the presence of T cells. It is not yet clear whether there is only one population of LPSresponsive B cells whose response is amplified by the action ofT cells or whether there are two populations of B cells, one activated directly by a B cell-LPS interaction independent of T cells, and another activated after LPS interacts with T cells.
Because LPS-induced Ig secretion was dependent on T cells in our experiments, we examined the amplifying effects of T cells from young and older autoimmune and normal mice on syngeneic and H-2-identical allogeneic LPS-stimulated B cells from young animals. T cells from young and older NZ and BXSB mice provided essentially the same degree of help, and this help was equal to that by T cells from H-2-matched normal strains. Thus, the heightened maturity of the B cells from these autoimmune mice apparently did not result from enhanced T-helper cell activity. The very interesting finding, however, was that the splenic T cells of the older MRL/I mice exerted excessive helper activity in vitro on isolated syngeneic B cells, compared to splenic T cells from young MRL/I mice and cells from young and older normal histocompatible mice. As we have demonstrated (10), the ratio of T to B cells is significantly greater in vivo than the maximal ratio employed in the present experiments in vitro. Therefore, one might well expect the helper activity observed in vitro to be greatly magnified in the intact animal. Splenic MRL/1 T cells also heightened in vitro production of anti-DNA antibodies by syngeneic and allogeneic cells (34) .
Therefore, the lpr gene in MRL/1 mice may hasten autoimmune disease by causing proliferation of helper T cells. However, such enhanced helper T-cell activity may not be necessarily a prerequisite for the development of autoimmunity because the congenic MRL/n substrain of mice that are devoid of the lpr gene do develop autoimmune disease, but much more slowly. The loss of suppressor T-cell function has been proposed (35, 36) . Circumstantial and experimental data both support and refute the concept that a numerical or functional defect in suppressor T cells is responsible for the disease of NZ mice. Thus, NZB X W hybrid spleen cells from older mice seem to be enhanced in the ability to mediate graft-versus-host reactions (37) and, after Con A stimulation, reduced in the ability to suppress pokeweed mitogen (PWM)-induced Ig secretion or anti-hapten responses (5) . Moreover, an inhibitory Ly 123 + T-cell subset may be absent or inoperative in NZB (6) and MRL/1 mice (38). However, as our studies with NZB, NZB × W, BXSB, and MRL/I mice indicated, nonspecific Con A-induced suppression of Ig synthesis in vitro is within normal levels very early in their lives and shortly before the clinical onset of overt disease. A possible explanation for the discrepancies in regard to antigen-nonspecific suppression in NZ mice may be that other investigators sometimes used cells from quite old animals, which we found in this study--as previously reported for NZ mice (22)--have far less capacity for polyclonal B stimulation than cells from young animals. This could result in an erroneous interpretation that suppression is lacking, whereas in actuality, polyclonal B-cell stimulation fails. Another difference is that we used LPS as polyclonal stimulation, whereas they used PWM (5). Although both mitogens induce polyclonal responses in the presence of T cells, and their effect is suppressed by Con A, the cellular requirements and the responsible factors may be different. Moreover, those investigators examined the suppressive effects of Con A at just one concentration, 2 ~g, whereas we used Con A at doses ranging from 0.5 to 20/~g. Concentrations of 2/zg Con A/culture, in most instances did not exert significant suppression for either autoimmune or normal strains in our system. At any rate, in agreement with our findings, others have shown that thymocyte-mediated antigen-nonspecific suppression is not lost with age in autoimmune hereditarily asplenic (Dh/+) NZB mice (39) or in conventional NZB mice (3). Moreover, suppressor cells, as defined with Ly 23 alloantigen-expressing cells in NZB mice (6) or /-J-subregion-controlled alloantigen in MRL/1 mice (10), are normal or elevated in numbers. Finally, NZ, MRL/I and BXSB mice are quite normal as far as antigen-specific suppression (40) (41) (42) and, with the exception of one study (43) , young syngeneic thymocytes repeatedly transferred into NZB and NZB × W mice had no inhibitory effect on autoantibody production or development of glomerulonephritis (44, 45) . The combined results prompt us to question the assignment of a suppressor T-cell defect as the major pathogenic mechanism of autoimmune disease. However, none of these arguments exclude the possible presence of subtle abnormalities of suppressor T cells undetectable in the assays employed or the development of late, secondary suppressor T cell or other immunoregulatory cell abnormalities in these animals. The claim that the defect in older NZB mice is an eventual lack of acceptor sites for suppressor messages on B cells (8) is not supported by our studies, because B cells from young and older NZB mice, as well as the other autoimmune strains, when stimulated with LPS to secrete Ig, were equally receptive to Con A-induced suppressor syngeneic and allogeneic T-cell messages.
It is now clear that all SLE strains have hypergammaglobulinemia, many kinds of autoantibodies, and spontaneous polyclonal antibody synthesis by B cells early in life. While still very young, NZB mice and their F1 hybrids undergo excessive B-cell activation and hypersecrete IgM; hypersecretion of IgM occurs in NZB fetal livers (3) and in NZB mice depleted of T cells (46) , all of which suggests an intrinsic defect or stimulation of these cells. According to genetic studies of crosses between NZB and SWR mice, NZB mice may have a subpopulation of hyperactive B cells whose number is determined by a dominant gene(s) and whose Ig production is controlled by a recessive gene(s) (3) . Further experiments with crosses of NZB and the B celldefective CBA/N mouse have shown that the NZB B-cell abnormality resulting in excessive Ig production occurs almost exclusively in that population of NZB cells affected by the CBA/N X-chromosome-linked defect (20, 47) . However, a role of T cells in the switch of B cells from IgM to IgG hypersecretion later in life has not yet been elucidated. How B-cell hyperactivity occurs in the other two autoimmune strains (MRL/1, BXSB) is not yet clear, but in MRL/1 mice an excessive T-helper cell component could be operative. Certainly the possibility that exogenous or endogenous polyclonal B-cell activators are responsible for initiating or enhancing B-cell activity should also be considered (4). However, our results strongly suggest that B-cell hyperactivity is not caused by numerical or functional defects in nonspecific suppressor T cells.
Summary
We have investigated in vitro the magnitude, nature, and regulation of spontaneous and mitogen-induced Ig secretion by splenic lymphocytes from several autoimmune murine strains (NZB, NZB × W, MRL/I, BXSB) and appropriate, normal mice. All autoimmune strains had increased numbers of mature splenic B lymphocytes, which secreted and/or contained Ig, compared to age-matched normal strains. In NZB and NZB × W mice, the high frequency of mature B cells was apparent early in life, whereas in MRL/1 and BXSB mice it was first noted shortly before the clinical onset of disease. Spleen cells from young autoimmune mice of all four strains secreted predominantly IgM, but with aging and the appearance of disease, the cells switched to IgG secretion predominantly. In contrast, spleen cells from normal mice were predominantly IgM secretors throughout the animals' lives. Approximately 15% of the total Ig-secreting cells in older NZB, NZB X W, and MRL mice were committed to secretion of anti-ssDNA antibodies. In both autoimmune and normal spleen cells, the B-cell population alone contained fewer secreting cells than the total lymphocyte population, indicating that T cells were required to achieve maximal levels of plaqueforming cells.
Spleen cells of NZB and NZB X W mice had a greater response to lipopolysaccharide (LPS) than other autoimmune and normal strains. Responsiveness to LPS, as measured by the frequency of induced Ig-secreting cells, was considerably diminished with age and onset of disease in all autoimmune but not in normal strains. LPSinduced Ig secretion by B cells of autoimmune and normal mice was subject to regulation by splenic T cells. No significant differences were observed between concanavalin-A (Con A) stimulated spleen cells from young and older autoimmune mice and normal control strains in effectively suppressing spontaneous and LPSinduced Ig secretion. Moreover, B cells from autoimmune mice and from normal strains were equally receptive to Con A-induced suppressor signals. T cells from young and older NZB and BXSB mice added to a standard number of B cells from syngeneic young mice provided equal help in enhancing LPS-induced Ig secretion, and this help in turn was equivalent to that provided by T cells from normal mice of the same H-2 haplotype. The exception was the MRL/1 strain; T cells from older animals provided considerably more help than T cells from young MRL/I or T cells from young and older H-2-eompatible normal mice.
